Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model

Yoko Kita, Takao Tanaka, Shigeto Yoshida, Naoya Oohara, Yasufumi Kaneda, Sachiko Kuwayama, Yumiko Muraki, Noriko Kanamaru, Satomi Hashimoto, Hiroko Takai, Chika Okada, Yukari Fukunaga, Yayoi Sakaguchi, Izumi Furukawa, Kyoko Yamada, Yoshikazu Inoue, Yuji Takemoto, Mariko Naito, Takeshi Yamada, Makoto MatsumotoDavid N. McMurray, E. C. Dela Cruz, E. V. Tan, R. M. Abalos, J. A. Burgos, Robert Gelber, Yasir Skeiky, Steven Reed, Mitsunori Sakatani, Masaji Okada

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

We have developed two novel tuberculosis (TB) vaccines: a DNA vaccine combination expressing mycobacterial heat shock protein 65 (Hsp65) and interleukin-12 (IL-12) by using the hemagglutinating virus of Japan (HVJ)-liposome (HSP65 + IL-12/HVJ) and a recombinant BCG harboring the 72f fusion gene (72f rBCG). These vaccines provide remarkable protective efficacy in mouse and guinea pig models, as compared to the current by available BCG vaccine. In the present study, we extended our studies to a cynomolgus monkey model, which is currently the best animal model of human tuberculosis, to evaluate the HSP65 + IL-12/HVJ and 72f rBCG vaccines. Vaccination with HSP65 + IL-12/HVJ as well as 72f rBCG vaccines provided better protective efficacy as assessed by the Erythrocyte Sedimentation Rate, chest X-ray findings and immune responses than BCG. Most importantly, HSP65 + IL-12/HVJ resulted in an increased survival for over a year. This is the first report of successful DNA vaccination and recombinant BCG vaccination against M. tuberculosis in the monkey model.

Original languageEnglish
Pages (from-to)2132-2135
Number of pages4
JournalVaccine
Volume23
Issue number17-18
DOIs
Publication statusPublished - Mar 18 2005
Externally publishedYes

Fingerprint

Sendai virus
Macaca fascicularis
Recombinant DNA
interleukin-12
Interleukin-12
Mycobacterium bovis
tuberculosis
Vaccination
Tuberculosis
vaccination
Japan
viruses
vaccines
DNA
Vaccines
Tuberculosis Vaccines
BCG vaccine
erythrocyte sedimentation rate
BCG Vaccine
DNA Vaccines

Keywords

  • HSP65 DNA + IL-12 DNA vaccine
  • Monkey
  • Tuberculosis

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Kita, Y., Tanaka, T., Yoshida, S., Oohara, N., Kaneda, Y., Kuwayama, S., ... Okada, M. (2005). Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. Vaccine, 23(17-18), 2132-2135. https://doi.org/10.1016/j.vaccine.2005.01.057

Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. / Kita, Yoko; Tanaka, Takao; Yoshida, Shigeto; Oohara, Naoya; Kaneda, Yasufumi; Kuwayama, Sachiko; Muraki, Yumiko; Kanamaru, Noriko; Hashimoto, Satomi; Takai, Hiroko; Okada, Chika; Fukunaga, Yukari; Sakaguchi, Yayoi; Furukawa, Izumi; Yamada, Kyoko; Inoue, Yoshikazu; Takemoto, Yuji; Naito, Mariko; Yamada, Takeshi; Matsumoto, Makoto; McMurray, David N.; Dela Cruz, E. C.; Tan, E. V.; Abalos, R. M.; Burgos, J. A.; Gelber, Robert; Skeiky, Yasir; Reed, Steven; Sakatani, Mitsunori; Okada, Masaji.

In: Vaccine, Vol. 23, No. 17-18, 18.03.2005, p. 2132-2135.

Research output: Contribution to journalArticle

Kita, Y, Tanaka, T, Yoshida, S, Oohara, N, Kaneda, Y, Kuwayama, S, Muraki, Y, Kanamaru, N, Hashimoto, S, Takai, H, Okada, C, Fukunaga, Y, Sakaguchi, Y, Furukawa, I, Yamada, K, Inoue, Y, Takemoto, Y, Naito, M, Yamada, T, Matsumoto, M, McMurray, DN, Dela Cruz, EC, Tan, EV, Abalos, RM, Burgos, JA, Gelber, R, Skeiky, Y, Reed, S, Sakatani, M & Okada, M 2005, 'Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model', Vaccine, vol. 23, no. 17-18, pp. 2132-2135. https://doi.org/10.1016/j.vaccine.2005.01.057
Kita, Yoko ; Tanaka, Takao ; Yoshida, Shigeto ; Oohara, Naoya ; Kaneda, Yasufumi ; Kuwayama, Sachiko ; Muraki, Yumiko ; Kanamaru, Noriko ; Hashimoto, Satomi ; Takai, Hiroko ; Okada, Chika ; Fukunaga, Yukari ; Sakaguchi, Yayoi ; Furukawa, Izumi ; Yamada, Kyoko ; Inoue, Yoshikazu ; Takemoto, Yuji ; Naito, Mariko ; Yamada, Takeshi ; Matsumoto, Makoto ; McMurray, David N. ; Dela Cruz, E. C. ; Tan, E. V. ; Abalos, R. M. ; Burgos, J. A. ; Gelber, Robert ; Skeiky, Yasir ; Reed, Steven ; Sakatani, Mitsunori ; Okada, Masaji. / Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. In: Vaccine. 2005 ; Vol. 23, No. 17-18. pp. 2132-2135.
@article{b2550e51590741e0bdfa895b5cdbfcd8,
title = "Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model",
abstract = "We have developed two novel tuberculosis (TB) vaccines: a DNA vaccine combination expressing mycobacterial heat shock protein 65 (Hsp65) and interleukin-12 (IL-12) by using the hemagglutinating virus of Japan (HVJ)-liposome (HSP65 + IL-12/HVJ) and a recombinant BCG harboring the 72f fusion gene (72f rBCG). These vaccines provide remarkable protective efficacy in mouse and guinea pig models, as compared to the current by available BCG vaccine. In the present study, we extended our studies to a cynomolgus monkey model, which is currently the best animal model of human tuberculosis, to evaluate the HSP65 + IL-12/HVJ and 72f rBCG vaccines. Vaccination with HSP65 + IL-12/HVJ as well as 72f rBCG vaccines provided better protective efficacy as assessed by the Erythrocyte Sedimentation Rate, chest X-ray findings and immune responses than BCG. Most importantly, HSP65 + IL-12/HVJ resulted in an increased survival for over a year. This is the first report of successful DNA vaccination and recombinant BCG vaccination against M. tuberculosis in the monkey model.",
keywords = "HSP65 DNA + IL-12 DNA vaccine, Monkey, Tuberculosis",
author = "Yoko Kita and Takao Tanaka and Shigeto Yoshida and Naoya Oohara and Yasufumi Kaneda and Sachiko Kuwayama and Yumiko Muraki and Noriko Kanamaru and Satomi Hashimoto and Hiroko Takai and Chika Okada and Yukari Fukunaga and Yayoi Sakaguchi and Izumi Furukawa and Kyoko Yamada and Yoshikazu Inoue and Yuji Takemoto and Mariko Naito and Takeshi Yamada and Makoto Matsumoto and McMurray, {David N.} and {Dela Cruz}, {E. C.} and Tan, {E. V.} and Abalos, {R. M.} and Burgos, {J. A.} and Robert Gelber and Yasir Skeiky and Steven Reed and Mitsunori Sakatani and Masaji Okada",
year = "2005",
month = "3",
day = "18",
doi = "10.1016/j.vaccine.2005.01.057",
language = "English",
volume = "23",
pages = "2132--2135",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "17-18",

}

TY - JOUR

T1 - Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model

AU - Kita, Yoko

AU - Tanaka, Takao

AU - Yoshida, Shigeto

AU - Oohara, Naoya

AU - Kaneda, Yasufumi

AU - Kuwayama, Sachiko

AU - Muraki, Yumiko

AU - Kanamaru, Noriko

AU - Hashimoto, Satomi

AU - Takai, Hiroko

AU - Okada, Chika

AU - Fukunaga, Yukari

AU - Sakaguchi, Yayoi

AU - Furukawa, Izumi

AU - Yamada, Kyoko

AU - Inoue, Yoshikazu

AU - Takemoto, Yuji

AU - Naito, Mariko

AU - Yamada, Takeshi

AU - Matsumoto, Makoto

AU - McMurray, David N.

AU - Dela Cruz, E. C.

AU - Tan, E. V.

AU - Abalos, R. M.

AU - Burgos, J. A.

AU - Gelber, Robert

AU - Skeiky, Yasir

AU - Reed, Steven

AU - Sakatani, Mitsunori

AU - Okada, Masaji

PY - 2005/3/18

Y1 - 2005/3/18

N2 - We have developed two novel tuberculosis (TB) vaccines: a DNA vaccine combination expressing mycobacterial heat shock protein 65 (Hsp65) and interleukin-12 (IL-12) by using the hemagglutinating virus of Japan (HVJ)-liposome (HSP65 + IL-12/HVJ) and a recombinant BCG harboring the 72f fusion gene (72f rBCG). These vaccines provide remarkable protective efficacy in mouse and guinea pig models, as compared to the current by available BCG vaccine. In the present study, we extended our studies to a cynomolgus monkey model, which is currently the best animal model of human tuberculosis, to evaluate the HSP65 + IL-12/HVJ and 72f rBCG vaccines. Vaccination with HSP65 + IL-12/HVJ as well as 72f rBCG vaccines provided better protective efficacy as assessed by the Erythrocyte Sedimentation Rate, chest X-ray findings and immune responses than BCG. Most importantly, HSP65 + IL-12/HVJ resulted in an increased survival for over a year. This is the first report of successful DNA vaccination and recombinant BCG vaccination against M. tuberculosis in the monkey model.

AB - We have developed two novel tuberculosis (TB) vaccines: a DNA vaccine combination expressing mycobacterial heat shock protein 65 (Hsp65) and interleukin-12 (IL-12) by using the hemagglutinating virus of Japan (HVJ)-liposome (HSP65 + IL-12/HVJ) and a recombinant BCG harboring the 72f fusion gene (72f rBCG). These vaccines provide remarkable protective efficacy in mouse and guinea pig models, as compared to the current by available BCG vaccine. In the present study, we extended our studies to a cynomolgus monkey model, which is currently the best animal model of human tuberculosis, to evaluate the HSP65 + IL-12/HVJ and 72f rBCG vaccines. Vaccination with HSP65 + IL-12/HVJ as well as 72f rBCG vaccines provided better protective efficacy as assessed by the Erythrocyte Sedimentation Rate, chest X-ray findings and immune responses than BCG. Most importantly, HSP65 + IL-12/HVJ resulted in an increased survival for over a year. This is the first report of successful DNA vaccination and recombinant BCG vaccination against M. tuberculosis in the monkey model.

KW - HSP65 DNA + IL-12 DNA vaccine

KW - Monkey

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=20044385066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044385066&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2005.01.057

DO - 10.1016/j.vaccine.2005.01.057

M3 - Article

C2 - 15755583

AN - SCOPUS:20044385066

VL - 23

SP - 2132

EP - 2135

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 17-18

ER -